{
    "clinical_study": {
        "@rank": "92393", 
        "acronym": "FOG", 
        "arm_group": [
            {
                "arm_group_label": "Training Group", 
                "arm_group_type": "Active Comparator", 
                "description": "There are 2 study visits.  Subjects in this group will complete the following:\nVisit 1\nGait evaluation\nNeuropsychological testing\nQuestionnaires and assessments\nTaught how to complete a visual problem-solving task (Tower of Hanoi)\nGiven a diary to record training at home.\nIn-home\n\u2022For 6 weeks at home, complete the in-home visual problem-solving tasks as instructed at Visit 1\nVisit 2\nGait evaluation\nNeuropsychological testing\nQuestionnaires and assessments"
            }, 
            {
                "arm_group_label": "Non Training Group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "There are 2 study visits.  Subjects in this group will complete the following:\nVisit 1\nGait evaluation\nNeuropsychological testing\nQuestionnaires and assessments\nVisit 2\nGait evaluation\nNeuropsychological testing\nQuestionnaires and assessments"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is designed to evaluate whether a specific visuospatial training task will change\n      gait performance of Parkinson's disease (PD) patients in doorways, specifically freezing of\n      gait."
        }, 
        "brief_title": "Freezing of Gait in Parkinson's Disease", 
        "condition": "Parkinson's Disease", 
        "condition_browse": {
            "mesh_term": "Parkinson Disease"
        }, 
        "detailed_description": {
            "textblock": "This study is a randomized, prospective, single-blinded six-week study in PD patients with\n      freezing of gait (FOG).\n\n      This study will involve 2 study groups:\n\n      Group A - training group; Group B - no training group/controls.\n\n      Both groups will complete a gait evaluation and neuropsychological testing.  Group A will\n      also practice an in-home visuospatial task for 30 minutes, 4-6 days per week for six weeks.\n      Group B will not complete the in-home tasks.\n\n      Participation in this study is expected to last 6-8 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age: greater than 18 years old and without an upper age limit\n\n          -  diagnosis of idiopathic PD exhibiting at least 2 or 3 cardinal signs (bradykinesia,\n             rigidity, and resting tremor)\n\n          -  Ambulate independently without an assistive device for at least 60 meters\n\n          -  Freezing of gait episodes confirmed through the FOG-Q and evaluation by a fellowship\n             trained Movement Disorder neurologist\n\n          -  Willingness and ability to participate in training and complete training diary\n\n          -  Documented FOG-Q and Unified Parkinson's Disease Rating Scale (UPDRS) II\n\n          -  Ability to sign informed consent\n\n          -  Pregnant females will be included in the study and there are no known risks to the\n             pregnant female or fetus\n\n        Exclusion Criteria:\n\n          -  Inability to complete questionnaires\n\n          -  Unwillingness to participate in training, complete all questionnaires and training\n             diary\n\n          -  Subjects with secondary causes of parkinsonism\n\n          -  Significant dementia (MOCA <20)\n\n          -  Prior deep brain stimulation (DBS) surgery or pallidotomy\n\n          -  Subjects cannot participate in any form of Physical Therapy, Occupational Therapy or\n             Speech Therapy during the study period\n\n          -  Subjects cannot start any new medications during the study period."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01887054", 
            "org_study_id": "Pro00045495"
        }, 
        "intervention": {
            "arm_group_label": "Training Group", 
            "intervention_name": "Tower of Hanoi", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "February 3, 2014", 
        "location": {
            "contact": {
                "last_name": "Deborah Boland, DO", 
                "phone": "919-668-2493"
            }, 
            "facility": {
                "address": {
                    "city": "Durham", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27705"
                }, 
                "name": "Duke University Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Visuospatial Training Tasks on Freezing of Gait in Parkinson's Disease", 
        "overall_official": {
            "affiliation": "Duke University", 
            "last_name": "Mark Stacy, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Primary outcome will be the percent of the gait cycle spent in DLS.  This will be evaluated using a GaitRite via a continuous walk, with subjects walking an 18-20 meter oval loop three times continuously.", 
            "measure": "Double Limb Support (DLS)", 
            "safety_issue": "No", 
            "time_frame": "6 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01887054"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Duke University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Duke University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}